[VRTX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 13.06%
YoY- 11.26%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,634,700 2,687,200 2,517,700 2,483,500 2,493,200 2,374,800 2,302,700 9.40%
PBT -3,391,200 1,279,100 1,147,600 1,179,200 1,161,500 891,500 1,076,800 -
Tax 202,400 179,500 178,800 143,900 245,800 191,700 257,900 -14.93%
NP -3,593,600 1,099,600 968,800 1,035,300 915,700 699,800 818,900 -
Tax Rate - -14.03% -15.58% -12.20% -21.16% -21.50% -23.95% -
Total Cost 6,228,300 1,587,600 1,548,900 1,448,200 1,577,500 1,675,000 1,483,800 160.44%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -136.40 40.92 38.48 41.69 36.73 29.47 35.56 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -13.92 4.26 3.76 4.01 3.55 2.72 3.19 -
EPS Diluted -13.92 4.21 3.71 3.97 3.52 2.69 3.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.